75N91024F00001↗
Mriglobal received this contract from Nih Nci, National Institutes of Health: $1.87M obligated so far for reference laboratory testing. Its period of performance ended 2026-09-17.
Key facts · data as of Oct 25, 2026
- Recipient
- Mriglobal
- Awarding agency
- National Institutes of Health (Department of Health and Human Services)
- Contracting office
- Nih Nci (75N910)
- Obligated to date
- $1.87M
- Potential value
- $1.87M
- Ends
- 2026-09-17
Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 25, 2026.
Cite this page: SpendQuery, Award 75N91024F00001, data as of Oct 25, 2026, https://spendquery.com/award?id=CONT_AWD_75N91024F00001_7529_75N91023D00010_7529
Mriglobal: all federal awards · Department of Health and Human Services: spending · Nih Nci: what it buys · The follow-on: recompete brief
THE SCOPE OF THIS TASK ORDER IS (1). PRODUCTION OF A DRUG SUBSTANCE, (2) CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT, (3) FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN THE CLINICAL TRIALS, AND (4) PRODUCTION OF A PLACEBO PRODUCT.
Up for re-bid: ends 2026-09-17. Recompete brief →
What it is
- Product or service
- Reference Laboratory Testing (PSC Q301)
- Industry
- Other Scientific and Technical Consulting Services (NAICS 541690)
- Contracting office
- Nih Nci (75N910)
- Competition
- Full and open competition
- Pricing
- Cost no fee
- How it was bought
- Single-award IDIQ · under 75N91023D00010
- Solicitation
- MLACV-2024-01
- Where the work is
- Jackson, MO · district MO-05
Obligations by fiscal year
SpendQuery holds FY2023 on; earlier years are on USAspending.gov.
Subcontractors: where the money went next
1 subaward totaling $1.62M (87.1% of what was obligated), as Mriglobal reported them. Primes report subawards of $30,000 or more; smaller ones and unreported ones aren't here.
| Subcontractor | Amount | Subawards | Where | First | Last |
|---|---|---|---|---|---|
| List Biological Laboratories, Inc. | $1.62M | 1 | CA | 2024-10-10 | 2024-10-10 |
The largest single subawards
| Date | To | Amount | For |
|---|---|---|---|
| 2024-10-10 | List Biological Laboratories, Inc. | $1.62M | PRODUCTION OF A DRUG SUBSTANCE, CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT,FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN CLINICAL TRIALS, AND PRODUCTION OF A PLACEBO PRODUCT. |
Every action
2 actions since 2024-09-17. Each is a modification or amendment with the money it added or took back.
| Date | Modification | Kind | Amount | What the agency wrote |
|---|---|---|---|---|
| 2025-03-19 | P00001 | Administrative change | $0 | THE SCOPE OF THIS TASK ORDER IS (1). PRODUCTION OF A DRUG SUBSTANCE, (2) CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT, (3) FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN THE CLINICAL TRIALS, AND (4) PRODUCTION OF A PLACEBO PRODUCT. |
| 2024-09-17 | 0 | $1.87M | THE SCOPE OF THIS TASK ORDER IS (1). PRODUCTION OF A DRUG SUBSTANCE, (2) CONVERSION OF DRUG SUBSTANCE TO DRUG PRODUCT, (3) FILLING DRUG PRODUCT INTO APPLICATORS TO BE USED IN THE CLINICAL TRIALS, AND (4) PRODUCTION OF A PLACEBO PRODUCT. |
Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-25). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗